Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Inhibition of Endocytosis of Clathrin-Mediated Angiotensin II Receptor Type 1 in Podocytes Augments Glomerular Injury.

Inoue K, Tian X, Velazquez H, Soda K, Wang Z, Pedigo CE, Wang Y, Cross E, Groener M, Shin JW, Li W, Hassan H, Yamamoto K, Mundel P, Ishibe S.

J Am Soc Nephrol. 2019 Sep 11. pii: ASN.2019010053. doi: 10.1681/ASN.2019010053. [Epub ahead of print]

PMID:
31511362
2.

The Association of Angiogenesis Markers With Acute Kidney Injury and Mortality After Cardiac Surgery.

Mansour SG, Zhang WR, Moledina DG, Coca SG, Jia Y, Thiessen-Philbrook H, McArthur E, Inoue K, Koyner JL, Shlipak MG, Wilson FP, Garg AX, Ishibe S, Parikh CR; TRIBE-AKI Consortium.

Am J Kidney Dis. 2019 Jul;74(1):36-46. doi: 10.1053/j.ajkd.2019.01.028. Epub 2019 Apr 5.

PMID:
30955944
3.

Podocyte histone deacetylase activity regulates murine and human glomerular diseases.

Inoue K, Gan G, Ciarleglio M, Zhang Y, Tian X, Pedigo CE, Cavanaugh C, Tate J, Wang Y, Cross E, Groener M, Chai N, Wang Z, Justice A, Zhang Z, Parikh CR, Wilson FP, Ishibe S.

J Clin Invest. 2019 Mar 1;129(3):1295-1313. doi: 10.1172/JCI124030. Epub 2019 Feb 18.

4.

New Insights into Diabetic Kidney Disease: The Potential Pathogenesis and Therapeutic Targets.

Liu WJ, Reiser J, Park TS, Liu Z, Ishibe S.

J Diabetes Res. 2017;2017:3945469. doi: 10.1155/2017/3945469. Epub 2017 Nov 8. No abstract available.

5.

Vinculin is required to maintain glomerular barrier integrity.

Lausecker F, Tian X, Inoue K, Wang Z, Pedigo CE, Hassan H, Liu C, Zimmer M, Jinno S, Huckle AL, Hamidi H, Ross RS, Zent R, Ballestrem C, Lennon R, Ishibe S.

Kidney Int. 2018 Mar;93(3):643-655. doi: 10.1016/j.kint.2017.09.021. Epub 2017 Dec 12.

6.

Talin regulates integrin β1-dependent and -independent cell functions in ureteric bud development.

Mathew S, Palamuttam RJ, Mernaugh G, Ramalingam H, Lu Z, Zhang MZ, Ishibe S, Critchley DR, Fässler R, Pozzi A, Sanders CR, Carroll TJ, Zent R.

Development. 2017 Nov 15;144(22):4148-4158. doi: 10.1242/dev.149914. Epub 2017 Oct 9.

7.

Loss of the podocyte glucocorticoid receptor exacerbates proteinuria after injury.

Zhou H, Tian X, Tufro A, Moeckel G, Ishibe S, Goodwin J.

Sci Rep. 2017 Aug 29;7(1):9833. doi: 10.1038/s41598-017-10490-z.

8.

Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice.

Beckerman P, Bi-Karchin J, Park AS, Qiu C, Dummer PD, Soomro I, Boustany-Kari CM, Pullen SS, Miner JH, Hu CA, Rohacs T, Inoue K, Ishibe S, Saleem MA, Palmer MB, Cuervo AM, Kopp JB, Susztak K.

Nat Med. 2017 Apr;23(4):429-438. doi: 10.1038/nm.4287. Epub 2017 Feb 20.

9.

Kidney Tubular Ablation of Ocrl/Inpp5b Phenocopies Lowe Syndrome Tubulopathy.

Inoue K, Balkin DM, Liu L, Nandez R, Wu Y, Tian X, Wang T, Nussbaum R, De Camilli P, Ishibe S.

J Am Soc Nephrol. 2017 May;28(5):1399-1407. doi: 10.1681/ASN.2016080913. Epub 2016 Nov 28.

10.

Targeting the podocyte cytoskeleton: from pathogenesis to therapy in proteinuric kidney disease.

Tian X, Ishibe S.

Nephrol Dial Transplant. 2016 Oct;31(10):1577-83. doi: 10.1093/ndt/gfw021. Epub 2016 Mar 10. Review.

11.

Essential Role of X-Box Binding Protein-1 during Endoplasmic Reticulum Stress in Podocytes.

Hassan H, Tian X, Inoue K, Chai N, Liu C, Soda K, Moeckel G, Tufro A, Lee AH, Somlo S, Fedeles S, Ishibe S.

J Am Soc Nephrol. 2016 Apr;27(4):1055-65. doi: 10.1681/ASN.2015020191. Epub 2015 Aug 24.

12.

Podocyte endocytosis in the regulation of the glomerular filtration barrier.

Inoue K, Ishibe S.

Am J Physiol Renal Physiol. 2015 Sep 1;309(5):F398-405. doi: 10.1152/ajprenal.00136.2015. Epub 2015 Jun 17. Review.

13.

Podocyte-associated talin1 is critical for glomerular filtration barrier maintenance.

Tian X, Kim JJ, Monkley SM, Gotoh N, Nandez R, Soda K, Inoue K, Balkin DM, Hassan H, Son SH, Lee Y, Moeckel G, Calderwood DA, Holzman LB, Critchley DR, Zent R, Reiser J, Ishibe S.

J Clin Invest. 2014 Mar;124(3):1098-113. doi: 10.1172/JCI69778. Epub 2014 Feb 17. Erratum in: J Clin Invest. 2015 Feb;125(2):882.

14.

The function of endocytosis in podocytes.

Soda K, Ishibe S.

Curr Opin Nephrol Hypertens. 2013 Jul;22(4):432-8. doi: 10.1097/MNH.0b013e3283624820. Review.

15.

Role of dynamin, synaptojanin, and endophilin in podocyte foot processes.

Soda K, Balkin DM, Ferguson SM, Paradise S, Milosevic I, Giovedi S, Volpicelli-Daley L, Tian X, Wu Y, Ma H, Son SH, Zheng R, Moeckel G, Cremona O, Holzman LB, De Camilli P, Ishibe S.

J Clin Invest. 2012 Dec;122(12):4401-11. doi: 10.1172/JCI65289. Epub 2012 Nov 26.

16.

Hepatocyte Growth Factor stimulated cell scattering requires ERK and Cdc42-dependent tight junction disassembly.

Togawa A, Sfakianos J, Ishibe S, Suzuki S, Fujigaki Y, Kitagawa M, Mellman I, Cantley LG.

Biochem Biophys Res Commun. 2010 Sep 17;400(2):271-7. doi: 10.1016/j.bbrc.2010.08.060. Epub 2010 Aug 20.

17.

Inhibition of podocyte FAK protects against proteinuria and foot process effacement.

Ma H, Togawa A, Soda K, Zhang J, Lee S, Ma M, Yu Z, Ardito T, Czyzyk J, Diggs L, Joly D, Hatakeyama S, Kawahara E, Holzman L, Guan JL, Ishibe S.

J Am Soc Nephrol. 2010 Jul;21(7):1145-56. doi: 10.1681/ASN.2009090991. Epub 2010 Jun 3.

18.

Deletion of the Met receptor in the collecting duct decreases renal repair following ureteral obstruction.

Ma H, Saenko M, Opuko A, Togawa A, Soda K, Marlier A, Moeckel GW, Cantley LG, Ishibe S.

Kidney Int. 2009 Oct;76(8):868-76. doi: 10.1038/ki.2009.304. Epub 2009 Aug 12.

19.

Met and the epidermal growth factor receptor act cooperatively to regulate final nephron number and maintain collecting duct morphology.

Ishibe S, Karihaloo A, Ma H, Zhang J, Marlier A, Mitobe M, Togawa A, Schmitt R, Czyczk J, Kashgarian M, Geller DS, Thorgeirsson SS, Cantley LG.

Development. 2009 Jan;136(2):337-45. doi: 10.1242/dev.024463.

20.

Epithelial-mesenchymal-epithelial cycling in kidney repair.

Ishibe S, Cantley LG.

Curr Opin Nephrol Hypertens. 2008 Jul;17(4):379-85. doi: 10.1097/MNH.0b013e3283046507. Review.

PMID:
18660674
21.

Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1.

Shibazaki S, Yu Z, Nishio S, Tian X, Thomson RB, Mitobe M, Louvi A, Velazquez H, Ishibe S, Cantley LG, Igarashi P, Somlo S.

Hum Mol Genet. 2008 Jun 1;17(11):1505-16. doi: 10.1093/hmg/ddn039. Epub 2008 Feb 7.

22.

Cell confluence regulates hepatocyte growth factor-stimulated cell morphogenesis in a beta-catenin-dependent manner.

Ishibe S, Haydu JE, Togawa A, Marlier A, Cantley LG.

Mol Cell Biol. 2006 Dec;26(24):9232-43. Epub 2006 Oct 9.

23.

Case 7-2006: a man with altered mental status and acute renal failure.

Schmitt R, Zhu X, Ishibe S.

N Engl J Med. 2006 Jun 22;354(25):2727-9; author reply 2727-9. No abstract available.

PMID:
16795153
24.

The polycystin 1-C-terminal fragment stimulates ERK-dependent spreading of renal epithelial cells.

Joly D, Ishibe S, Nickel C, Yu Z, Somlo S, Cantley LG.

J Biol Chem. 2006 Sep 8;281(36):26329-39. Epub 2006 Jun 21.

25.

Expression of neutrophil gelatinase-associated lipocalin regulates epithelial morphogenesis in vitro.

Gwira JA, Wei F, Ishibe S, Ueland JM, Barasch J, Cantley LG.

J Biol Chem. 2005 Mar 4;280(9):7875-82. Epub 2005 Jan 6.

26.
27.
28.
29.

Nephrogenic fibrosing dermopathy: an unusual skin condition associated with kidney disease.

Perazella MA, Ishibe S, Perazella MA, Reilly RF.

Semin Dial. 2003 May-Jun;16(3):276-80.

PMID:
12753692
30.

An NMR study on the interaction of Escherichia coli DinI with RecA-ssDNA complexes.

Yoshimasu M, Aihara H, Ito Y, Rajesh S, Ishibe S, Mikawa T, Yokoyama S, Shibata T.

Nucleic Acids Res. 2003 Mar 15;31(6):1735-43.

31.

[Survey on leisure of nursing students in junior college].

Ono K, Ishibe S, Kamezaki S.

Kango Tenbo. 1984 Nov;9(11):1045-51, 1055. Japanese. No abstract available.

PMID:
6569293

Supplemental Content

Loading ...
Support Center